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FOREWORD
Current Perspectives inAcid Inhibitory Therapy
These proceedings ofthe meeting "Current Perspectives inAcid Inhibitory Therapy"
provide a unique overview of our present knowledge of the subject. Without the support
of Byk-Gulden, it would not have been possible to assemble this extraordinary group of
experts nor produce such a broad assessment ofthe present state ofknowledge in the area
of acid peptic disease. On behalf of the Yale School of Medicine and Yale University, I
would like to express our deep gratitude to Byk-Gulden both for their generosity and the
fine spirit ofpartnership that underscored the establishment ofthis symposium.
The subject ofacid secretion anddigestion is worthy ofsomeconsideration. Forthou-
sands of years, man has contemplated his place in the universe. The earliest writings
address issues of the cosmos and the meanings oflife, endlessly examining the nature of
divinity, pantheism and the fate of the soul. Nevertheless, throughout these erudite texts
runs a common and fundamental issue adumbrated upon both in metaphor and fact -
digestion! The commonality offood, the stomach and digestion can be noted in writings
as divergent as the Sufi mystics, the Sephardic sages, philosophers ofthe Tang dynasty or
the odes ofthe Mantuan bard. Food and its digestion represent a theme ofhuman interest
equaled only by preoccupation with the ephemeral concept of love. Man is and becomes
what he eats - Homo est quod est. It is, therefore, no wonder that the subject ofdiges-
tion has been a matter ofconcern to doctors and theirpatients for as long as records exist.
Human concern about diet and the stomach reflects the dim and dubious origins ofratio-
nal medicine itself. The Greeks recognized by long experience of trial and error that
cooked food was safer than raw; that the sick stomach benefited from a sloppy diet; to
defer eating until the decline of a fever; and to strike a sensible balance between gluttony
and abstinence. Such early observations established the basis for the initiation of a ratio-
nal therapy as expounded in the classic comment ofCelsius, "In this way, medicine arose
from the experience ofthe recovery ofsome, the death ofothers, differentiating the harm-
ful from the salutary things." The recognition that different kinds offood might engender
a lightermood andrelieve melancholy was followed by an appreciation ofthe relationship
ofdiet to both psyche and soma. In the earliest Greek writings, the efforts ofthe body to
bring the humors from a raw fermented status (apepsia) to normal (pepsis) was associat-
ed with the idea of cookery or coction. A view of the digestive processes that survived
until well into the seventeenth century!
Up until the time of Beaumont's studies, the physiology of gastric digestion was
obfuscated by a series ofmutually contradictory studies, which were best summarized in
Hunter's epigram that the stomach was variously regarded as amill, afermenting wine vat
or a stew-pan. The identification ofgastric acidity as an internally generated event and its
relationship to digestion was a phenomenon ofthe early nineteenth century.
Unfortunately, little rational therapeutic intervention was available for the treatment
ofgastric disorders. Indeed, up until the late nineteenth century, the stomach was often not
clearly recognized as a source ofsymptoms. Nevertheless, from the earliest times, chalk,
charcoal and slop diets had been noted to provide symptomatic relieffrom dyspepsia. The
recognition in this first part of the century that the mucosal damage was caused by acid
(no acid - noulcer) andthatthis acid could bedecreasedby luminal neutralization result-
ed in a wave ofenthusiasm for antacid preparations, bland diets and milk infusion as ther-
apeutic options. The subsequent identification ofthe histamine 2 receptor subtype and the
development of agents specifically capable ofblocking acid secretion revolutionized the
management of the disease process and virtually obliterated surgery as a therapeutic
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option for peptic ulcer except in cases ofemergency. The more recent identification ofthe
specific molecular mechanism the proton pump - resulted in the development of a
new class of therapeutic agents the proton pump inhibitors. By precisely defining the
pump as the therapeutic target, an almost complete inhibition ofacid secretion with con-
sequent therapeutic efficacy, hitherto as yet undreamed of, has been achieved.
Unfortunately, as in alljourneys, the horizon may not only appear to recede but fur-
ther obstacles supervene. Of note, in this respect, was the identification ofHelicobacter
pylori in the gastric mucosa and its correlation with ulcer disease. It is, thus, likely that
abrogation of acid secretion by pump blockade will necessarily need to be supported by
the development of pharmacological strategies also designed to eradicate the bacterial
pathogen. Implicit in this observation ofa novel pathogen was the realization that the his-
torical concept of a "locus minoris resistentiae" might yet apply to the stomach and its
environs. Could it be that the mucosa itselfmight be intrinsically vulnerable or that local
repair processes themselves might be flawed and, hence, responsible for inadequate heal-
ing?
As one writes this coda, it is clearly apparent that further issues of the mucosal
conundrum ofdamage and healing yet remain to be resolved. In particular, the role ofthe
prolate elipsoid, pepsin and the trefoil motif group of growth factors need clarification.
The current status ofwound healing ofthe mucosa is probably best reflected in the adage
of the great French surgeon Ambroise Pare, "Je lepansay, Dieu le guarit." Nevertheless,
great progress has been made and, as this meeting proceedings will show, much has been
accomplished.
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